Vanguard Group’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $441K | Sell |
231,892
-37,025
| -14% | -$70.3K | ﹤0.01% | 3945 |
|
2025
Q1 | $1.9M | Sell |
268,917
-4,446
| -2% | -$31.5K | ﹤0.01% | 3507 |
|
2024
Q4 | $6.02M | Sell |
273,363
-7,995
| -3% | -$176K | ﹤0.01% | 3192 |
|
2024
Q3 | $5.65M | Buy |
281,358
+5,023
| +2% | +$101K | ﹤0.01% | 3225 |
|
2024
Q2 | $4.81M | Buy |
276,335
+15,411
| +6% | +$268K | ﹤0.01% | 3274 |
|
2024
Q1 | $10.9M | Sell |
260,924
-6,038
| -2% | -$252K | ﹤0.01% | 2912 |
|
2023
Q4 | $6.72M | Buy |
266,962
+6,138
| +2% | +$154K | ﹤0.01% | 3164 |
|
2023
Q3 | $8.53M | Buy |
260,824
+1,253
| +0.5% | +$41K | ﹤0.01% | 2970 |
|
2023
Q2 | $15.1M | Buy |
259,571
+114,761
| +79% | +$6.68M | ﹤0.01% | 2716 |
|
2023
Q1 | $3.78M | Buy |
144,810
+25,464
| +21% | +$665K | ﹤0.01% | 3432 |
|
2022
Q4 | $3.56M | Buy |
119,346
+12,409
| +12% | +$370K | ﹤0.01% | 3451 |
|
2022
Q3 | $5.49M | Buy |
106,937
+83,098
| +349% | +$4.26M | ﹤0.01% | 3275 |
|
2022
Q2 | $690K | Buy |
23,839
+2,066
| +9% | +$59.8K | ﹤0.01% | 4200 |
|
2022
Q1 | $1.14M | Sell |
21,773
-9,335
| -30% | -$490K | ﹤0.01% | 4165 |
|
2021
Q4 | $2.14M | Sell |
31,108
-37
| -0.1% | -$2.54K | ﹤0.01% | 4008 |
|
2021
Q3 | $4.94M | Buy |
31,145
+1,224
| +4% | +$194K | ﹤0.01% | 3669 |
|
2021
Q2 | $5.83M | Buy |
29,921
+5,368
| +22% | +$1.05M | ﹤0.01% | 3514 |
|
2021
Q1 | $6.34M | Buy |
24,553
+54
| +0.2% | +$14K | ﹤0.01% | 3400 |
|
2020
Q4 | $4.73M | Buy |
24,499
+586
| +2% | +$113K | ﹤0.01% | 3386 |
|
2020
Q3 | $4.86M | Sell |
23,913
-108
| -0.4% | -$21.9K | ﹤0.01% | 3167 |
|
2020
Q2 | $6.72M | Sell |
24,021
-614
| -2% | -$172K | ﹤0.01% | 2954 |
|
2020
Q1 | $7.39M | Buy |
24,635
+612
| +3% | +$184K | ﹤0.01% | 2762 |
|
2019
Q4 | $7.71M | Buy |
24,023
+5,959
| +33% | +$1.91M | ﹤0.01% | 2981 |
|
2019
Q3 | $6.89M | Buy |
18,064
+637
| +4% | +$243K | ﹤0.01% | 3016 |
|
2019
Q2 | $7.84M | Buy |
17,427
+14,551
| +506% | +$6.55M | ﹤0.01% | 2990 |
|
2019
Q1 | $1.5M | Buy |
2,876
+1,108
| +63% | +$579K | ﹤0.01% | 3527 |
|
2018
Q4 | $739K | Buy |
1,768
+180
| +11% | +$75.2K | ﹤0.01% | 3647 |
|
2018
Q3 | $463K | Hold |
1,588
| – | – | ﹤0.01% | 3866 |
|
2018
Q2 | $1.04M | Buy |
1,588
+680
| +75% | +$444K | ﹤0.01% | 3675 |
|
2018
Q1 | $3.74M | Buy |
+908
| New | +$3.74M | ﹤0.01% | 3256 |
|